Evidence map›Paper›PMID 38715127›Full record

ArticleJournal of neuroinflammation2024

Implication of system x

Pauline Beckers, Inês Belo Do Nascimento, Mathilde Charlier, Nathalie Desmet, Ann Massie, Emmanuel Hermans

Abstract read
In one paragraph

Article in Journal of neuroinflammation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Pauline BeckersInstitute of Neuroscience, Group of Neuropharmacology, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 53 (B1.53.01), Brussels, 1200, Belgium.
Inês Belo Do NascimentoInstitute of Neuroscience, Group of Neuropharmacology, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 53 (B1.53.01), Brussels, 1200, Belgium.
Mathilde CharlierInstitute of Neuroscience, Group of Neuropharmacology, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 53 (B1.53.01), Brussels, 1200, Belgium.
Nathalie DesmetInstitute of Neuroscience, Group of Neuropharmacology, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 53 (B1.53.01), Brussels, 1200, Belgium.
Ann MassieNeuro-Aging & Viro-Immunotherapy, Center for Neurosciences, Vrije Universiteit Brussel (VUB), Laarbeeklaan 103, Brussels, 1090, Belgium.
Emmanuel HermansInstitute of Neuroscience, Group of Neuropharmacology, Université catholique de Louvain (UCLouvain), Avenue Hippocrate 53 (B1.53.01), Brussels, 1200, Belgium. emmanuel.hermans@uclouvain.be.

Funding

Funds for Scientific research J.0106.24Strategic Research Program of VUB SRP49
6 · The paper itself

Abstract

backgroundDespite the high prevalence of neuropathic pain, treating this neurological disease remains challenging, given the limited efficacy and numerous side effects associated with current therapies. The complexity in patient management is largely attributed to an incomplete understanding of the underlying pathological mechanisms. Central sensitization, that refers to the adaptation of the central nervous system to persistent inflammation and heightened excitatory transmission within pain pathways, stands as a significant contributor to persistent pain. Considering the role of the cystine/glutamate exchanger (also designated as system x

methodsWe examined the implication of system x

resultsThe sciatic nerve lesion was found to upregulate system x

conclusionTogether, these observations provide evidence for a role of system x

Indexed as

Amino Acid Transport System y+NeuralgiaNeuroinflammatory DiseasesAnimalsBiomarkersFemaleGlial Fibrillary Acidic ProteinGliosisGlutamic AcidHyperalgesiaMiceMice, TransgenicMicrogliaPhenotypeReproducibility of ResultsRNA, MessengerAmino Acid Transport System y+BiomarkersGlial Fibrillary Acidic Proteinglial fibrillary astrocytic protein, mouseGlutamic AcidRNA, MessengerSlc7a11 protein, mouseSulfasalazineCentral sensitizationChronic painGlial cellsGlutamateInflammationSlc7a11Spinal cordxCT

Identifiers

PMID38715127
PMCPMC11077843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.